<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134768</url>
  </required_header>
  <id_info>
    <org_study_id>CAE.1C.D.10</org_study_id>
    <nct_id>NCT03134768</nct_id>
  </id_info>
  <brief_title>Effect of Birth on Immunological Parameters in Cord Blood</brief_title>
  <official_title>To Investigate the Immediate Effect of Birth on Immunological Parameters in Cord Blood, and Compare With Data of CS Born Infants Collected in the JULIUS SN Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Asia Pacific Holdings Pte, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Asia Pacific Holdings Pte, Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to understand the immediate effect of birth on immunological
      parameters in vaginally born cord blood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main purpose of the study is to understand the immediate effect of birth on immunological
      parameters in vaginally born cord blood and also whether mode and duration of delivery has an
      influence on immune parameters in cord blood.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2, 2016</start_date>
  <completion_date type="Anticipated">March 20, 2018</completion_date>
  <primary_completion_date type="Actual">November 16, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cytokines profile in cord blood plasma</measure>
    <time_frame>1 year</time_frame>
    <description>Following cytokines will be part of the profile: IL-6, IL-1, IL-2, IL-4, IL-5, IL-7, IL-8, IL-10, IL12p70, IL-13, IL-17, G-CSF, GM-CSF, IFNg, MCP-1(MCAF), MIP-1b, TNFa</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cord blood Immunoglobulin levels</measure>
    <time_frame>1 year</time_frame>
    <description>Immunoglobulin levels will be measured in cord blood plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Allergen stimulated cytokine expression in the supernatants of Cord blood mononuclear cells (CBMC)</measure>
    <time_frame>1 year</time_frame>
    <description>Cellular response to allergen stimulation will be measured in supernatants</description>
  </primary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Immunologic Activity Alteration</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>This is not an interventional study</intervention_name>
    <description>This is an observational study</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      cord blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant mothers undergoing normal vaginal delivery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant mothers undergoing normal vaginal delivery

        Exclusion Criteria:

          -  Use of non-steroidal anti-inflammatory drugs (NSAIDs) 2 weeks prior to birth

               -  Antenatal antibiotics treatment (2 weeks prior to birth)

               -  Diabetes mellitus requiring insulin treatment during pregnancy

               -  Uncontrollable Hyperthyroidism during pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant mothers</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Sandalova, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Danone Asia Pacific Holdings Ltd</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Goh, MD</last_name>
    <role>Study Chair</role>
    <affiliation>KK Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mei Chin Chua, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KK Hospital</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

